Similar articles

• L-6-ketopiperidine-2-carbonyl-L-leucyl-L-proline amide as a novel thyrotropin releasing hormone analogue with improving effects on impaired central nervous systems functions.

  Oka M, Ochi Y, Furukawa K, Ito T, Miura Y, Karasawa T, Kadokawa T. Oka M, et al. Arzneimittelforschung. 1989 Mar;39(3):297-303. Arzneimittelforschung. 1989. PMID: 2547386
• [Biogenic amines and thyrotropin-releasing hormone (TRH) (author's transl)].

  Narumi S, Nagawa Y. Narumi S, et al. Tanpakushitsu Kakusan Koso. 1981 Aug;26(11):1702-7. Tanpakushitsu Kakusan Koso. 1981. PMID: 6795680 Review. Japanese. No abstract available.
• [TRH, its function and receptor].

  Saito S, Oshima L. Saito S, et al. Nihon Rinsho. 1981 Sep;39(9):2921-7. Nihon Rinsho. 1981. PMID: 6279921 Review. Japanese. No abstract available.
• [Effect of endotoxemia on thyrotropin releasing hormone and its receptor in Wistar rat brain].

  Wang XC, Liu BY, Xu P, Jing H. Wang XC, et al. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2003 Oct;15(10):622-4. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2003. PMID: 14552689 Chinese.
• Prolyl-leucyl-glycine amide (PLG) and thyrotropin-releasing hormone (TRH): DOPA potentiation and biogenic amine studies.

  Plotnikoff NP. Plotnikoff NP. Prog Brain Res. 1975;42:11-23. doi: 10.1016/S0079-6123(08)63637-7. Prog Brain Res. 1975. PMID: 730 No abstract available.